Literature DB >> 21083419

A bilayer construct controls adipose-derived stem cell differentiation into endothelial cells and pericytes without growth factor stimulation.

Shanmugasundaram Natesan1, Ge Zhang, David G Baer, Thomas J Walters, Robert J Christy, Laura J Suggs.   

Abstract

This work describes the differentiation of adipose-derived mesenchymal stem cells (ASC) in a composite hydrogel for use as a vascularized dermal matrix. Our intent is that such a construct could be utilized following large-surface-area burn wounds that require extensive skin grafting and that are limited by the availability of uninjured sites. To develop engineered skin replacement constructs, we are pursuing the use of ASC. We have established that a PEGylated fibrin gel can provide a suitable environment for the proliferation of ASC over a 7 day time course. Further, we have demonstrated that PEGylated fibrin can be used to control ASC differentiation toward vascular cell types, including cells characteristic of both endothelial cells and pericytes. Gene expression analysis revealed strong upregulation of endothelial markers, CD31, and von Willebrand factor, up to day 11 in culture with corresponding evidence of protein expression demonstrated by immunocytochemical staining. ASC were not only shown to express endothelial cell phenotype, but a subset of the ASC expressed pericyte markers. The NG2 gene was upregulated over 11 days with corresponding evidence for the cell surface marker. Platelet-derived growth factor receptor beta gene expression decreased as the multipotent ASC differentiated up to day 7. Increased receptor expression at day 11 was likely due to the enhanced pericyte gene expression profile, including increased NG2 expression. We have also demonstrated that when cells are loaded onto chitosan microspheres and sandwiched between the PEGylated fibrin gel and a type I collagen gel, the cells can migrate and proliferate within the two different gel types. The matrix composition dictates the lineage specification and is not driven by soluble factors. Utilizing an insoluble bilayer matrix to direct ASC differentiation will allow for the development of both vasculature as well as dermal connective tissue from a single population of ASC. This work underscores the importance of the extracellular matrix in controlling stem cell phenotype. It is our goal to develop layered composites as wound dressings or vascularized dermal equivalents that are not limited by nutrient diffusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21083419      PMCID: PMC3117235          DOI: 10.1089/ten.TEA.2010.0294

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  52 in total

1.  Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering.

Authors:  S Jockenhoevel; G Zund; S P Hoerstrup; K Chalabi; J S Sachweh; L Demircan; B J Messmer; M Turina
Journal:  Eur J Cardiothorac Surg       Date:  2001-04       Impact factor: 4.191

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

4.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

5.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering.

Authors:  Q Ye; G Zünd; P Benedikt; S Jockenhoevel; S P Hoerstrup; S Sakyama; J A Hubbell; M Turina
Journal:  Eur J Cardiothorac Surg       Date:  2000-05       Impact factor: 4.191

6.  A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells.

Authors:  Bin Han; Ivan R Schwab; Trista K Madsen; R Rivkah Isseroff
Journal:  Cornea       Date:  2002-07       Impact factor: 2.651

7.  Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.

Authors:  Per Lindblom; Holger Gerhardt; Stefan Liebner; Alexandra Abramsson; Maria Enge; Mats Hellstrom; Gudrun Backstrom; Simon Fredriksson; Ulf Landegren; Henrik C Nystrom; Goran Bergstrom; Elisabetta Dejana; Arne Ostman; Per Lindahl; Christer Betsholtz
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361

8.  Copper chelation represses the vascular response to injury.

Authors:  Lazar Mandinov; Anna Mandinova; Stanimir Kyurkchiev; Dobroslav Kyurkchiev; Ivan Kehayov; Vihren Kolev; Raffaella Soldi; Cinzia Bagala; Ebo D de Muinck; Volkhard Lindner; Mark J Post; Michael Simons; Stephen Bellum; Igor Prudovsky; Thomas Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

Review 9.  Tissue engineering strategies for in vivo neovascularisation.

Authors:  Alessandra B Ennett; David J Mooney
Journal:  Expert Opin Biol Ther       Date:  2002-12       Impact factor: 4.388

10.  Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute.

Authors:  Motoharu Hojo; Sadaki Inokuchi; Masako Kidokoro; Naoto Fukuyama; Etsuro Tanaka; Chizuko Tsuji; Muneo Miyasaka; Ryuzaburo Tanino; Hiroe Nakazawa
Journal:  Plast Reconstr Surg       Date:  2003-04-15       Impact factor: 4.730

View more
  24 in total

1.  A PEGylated fibrin hydrogel-based antimicrobial wound dressing controls infection without impeding wound healing.

Authors:  Joel Gil; Shanmugasundaram Natesan; Jie Li; Jose Valdes; Andrew Harding; Michael Solis; Stephen C Davis; Robert J Christy
Journal:  Int Wound J       Date:  2017-08-02       Impact factor: 3.315

2.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions.

Authors:  Daphne L Hutton; Elizabeth A Logsdon; Erika M Moore; Feilim Mac Gabhann; Jeffrey M Gimble; Warren L Grayson
Journal:  Tissue Eng Part A       Date:  2012-05-09       Impact factor: 3.845

3.  Engineering a bilayered hydrogel to control ASC differentiation.

Authors:  Shanmugasundaram Natesan; David O Zamora; Laura J Suggs; Robert J Christy
Journal:  J Vis Exp       Date:  2012-05-25       Impact factor: 1.355

Review 4.  Dedifferentiated fat cells: A cell source for regenerative medicine.

Authors:  Medet Jumabay; Kristina I Boström
Journal:  World J Stem Cells       Date:  2015-11-26       Impact factor: 5.326

Review 5.  Biomaterials to prevascularize engineered tissues.

Authors:  Lei Tian; Steven C George
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

Review 6.  Augmenting peripheral nerve regeneration using stem cells: A review of current opinion.

Authors:  Neil G Fairbairn; Amanda M Meppelink; Joanna Ng-Glazier; Mark A Randolph; Jonathan M Winograd
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

7.  The role of adipose-derived stem cells in a self-organizing 3D model with regard to human soft tissue healing.

Authors:  Martin Oberringer; Monika Bubel; Martina Jennewein; Silke Guthörl; Tamara Morsch; Sophie Bachmann; Wolfgang Metzger; Tim Pohlemann
Journal:  Mol Cell Biochem       Date:  2018-01-05       Impact factor: 3.396

Review 8.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

9.  Compression-induced structural and mechanical changes of fibrin-collagen composites.

Authors:  O V Kim; R I Litvinov; J Chen; D Z Chen; J W Weisel; M S Alber
Journal:  Matrix Biol       Date:  2016-10-15       Impact factor: 11.583

10.  Human adipose-derived cells can serve as a single-cell source for the in vitro cultivation of vascularized bone grafts.

Authors:  Cristina Correia; Warren Grayson; Ryan Eton; Jeffrey M Gimble; Rui A Sousa; Rui L Reis; Gordana Vunjak-Novakovic
Journal:  J Tissue Eng Regen Med       Date:  2012-08-17       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.